- Authorisation - controlling risks and encouraging substitution
- REACH 2018: Find your co-registrants
- Know your rights when negotiating for data
- Substance identification needs strong analytical data
- Upcoming in 2016: Completeness check to enhance availability of information
- What to know about...REACH authorisation
- So much information, so little space
- Reaching out to downstream users
- Downstream users: notify ECHA if you use an authorised substance
- Nanomaterials - new data available
- ECHA Helpdesk's top tips: How to change your company name or legal personality?
- Replacing harmful chemicals – the American way
- Chemical leasing - the way forward?
- Guest column: Belle Busybody raises awareness about chemicals
Send your feedback to:echanewsletter (at) echa.europa.eu
Article related to: REACH
What to know about...REACH authorisation
Authorisation is the "A" in REACH. It's all about making sure that the risks from hazardous substances are properly controlled and that these substances are progressively replaced by safer alternatives. Authorisation is not about banning substances, but more about guiding safe use and giving industry time to find replacement substances or technologies.
The three-phase authorisation process begins when an EU Member State or ECHA proposes that a chemical be identified as a substance of very high concern (SVHC). This proposal is made public in 'the registry of intentions' to give advanced notice to industry and other stakeholders.
- Registry of intentions
- Candidate List
- Authorisation List (Annex XIV of REACH)
- ECHA's web pages on substitution
Did you know?
Substances of very high concern
SVHCs are, for example:
The Candidate List currently has 163 substances. The Authorisation List has 31 substances.
Authorisation applications so far
ECHA has delivered 50 opinions on applications for authorisation to the European Commission. The Commission has issued 10 decisions:
Currently, 40 authorisation decisions are pending with the Commission.
There are seven substances (musk xylene, MDA, DIBP, BBP, diarsenic pentoxide, TCEP and 2,4-DNT) for which the latest application date has passed and no applications for authorisation have been submitted.
Text by Nedyu Yasenov
Top image: Three phases of REACH authorisation
| || |
Sign in to comment and/or rate this article.
Committee for Risk Assessment:
25-28 November 2019 and
3-5 December 2019
Committee for Socio-Economic
26-28 November 2019 and
3-5 December 2019
Member State Committee:
9-11 December 2019
3-7 February 2020 (tentative)
Biocidal Products Committee:
10-11 December 2019
Management Board meeting:
12-13 December 2019